• Publications
  • Influence
Update on AUA guideline on the management of benign prostatic hyperplasia.
TLDR
To revise the 2003 version of the American Urological Association's (AUA) Guideline on the management of benign prostatic hyperplasia, new pharmacotherapies and technologies have emerged which have impacted treatment algorithms. Expand
Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial.
TLDR
PVP is a unique, safe and effective outpatient modality that provides immediate symptomatic and urodynamic relief of bladder outlet obstruction secondary to BPH and long-term followup is needed to validate further the maintenance of clinical efficacy beyond 1 year. Expand
Laparoscopic radical cystoprostatectomy with ileal conduit performed completely intracorporeally: the initial 2 cases.
TLDR
It is believed that with further experience and refinement in the operative technique, laparoscopic radical cystoprostatectomy with ileal conduit urinary diversion may become an attractive treatment option for selected candidates with localized muscle-invasive bladder cancer. Expand
PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time.
TLDR
Analysis of prostate-specific antigen (PSA) kinetics in patients treated with prostate brachytherapy (PI) with a minimum of 5 years of PSA follow-up found patients experiencing a PSA bounce are more likely to be younger and will have a better bRFS. Expand
Impact of prostate‐specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study
TLDR
The overall results from the high‐power KTP laser prostatectomy were positive and durable, and it was suggested that there was a significant difference in efficacy between patients presenting with a total PSA of <6 or >6 ng/mL. Expand
Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
TLDR
The UroVysion FISH assay provides high sensitivity and specificity to detect transitional cell carcinoma in cytologically equivocal and negative urine samples, and emphasize the important role of this assay in the management of bladder cancer. Expand
Laparoscopic radical cystectomy and continent orthotopic ileal neobladder performed completely intracorporeally: the initial experience.
TLDR
Laproscopic radical cystectomy and orthotopic ileal neobladder performed completely intracorporeally are feasible and 1 patient died of metastatic disease, while the other 2 are doing well without local or systematic progression. Expand
Successful outcomes in pheochromocytoma surgery in the modern era.
TLDR
Preoperative alpha-adrenergic blockade is not essential in pheochromocytoma patients and calcium channel blockers are just as effective and safer when used as the primary mode of antihypertensive therapy. Expand
PSA bounce predicts early success in patients with permanent iodine-125 prostate implant.
TLDR
Immediate salvage therapy in patients with a rising PSA level after permanent prostate brachytherapy should not be initiated provided the PSA increase does not exceed the pretreatment PSA value. Expand
Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer.
TLDR
The goal was to determine whether the primary grade of biopsy Gleason score (GS) 7 prostate cancer (CaP) was predictive for biochemical relapse-free survival (bRFS), and whether the biopsy GS used at the time of medical decision making predicted for the biochemical outcome. Expand
...
1
2
3
4
5
...